Limiting angiogenesis to modulate scar formation

Adv Drug Deliv Rev. 2019 Jun:146:170-189. doi: 10.1016/j.addr.2018.02.010. Epub 2018 Mar 3.

Abstract

Angiogenesis, the process of new blood vessel formation from existing blood vessels, is a key aspect of virtually every repair process. During wound healing an extensive, but immature and leaky vascular plexus forms which is subsequently reduced by regression of non-functional vessels. More recent studies indicate that uncontrolled vessel growth or impaired vessel regression as a consequence of an excessive inflammatory response can impair wound healing, resulting in scarring and dysfunction. However, in order to elucidate targetable factors to promote functional tissue regeneration we need to understand the molecular and cellular underpinnings of physiological angiogenesis, ranging from induction to resolution of blood vessels. Especially for avascular tissues (e.g. cornea, tendon, ligament, cartilage, etc.), limiting rather than boosting vessel growth during wound repair potentially is beneficial to restore full tissue function and may result in favourable long-term healing outcomes.

Keywords: Angiogenesis; Cartilage; Cornea; Embryonic vascularisation; Fetal; Fibrotic response; Scar-free healing; Scarring; Tendon; VEGF.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Cicatrix / drug therapy
  • Cicatrix / metabolism*
  • Cicatrix / pathology
  • Drug Delivery Systems
  • Humans
  • Inflammation / drug therapy
  • Inflammation / metabolism
  • Inflammation / pathology
  • Neovascularization, Pathologic / drug therapy
  • Neovascularization, Pathologic / metabolism*
  • Neovascularization, Pathologic / pathology
  • Protein Kinase Inhibitors / chemistry
  • Protein Kinase Inhibitors / pharmacology
  • Wound Healing / drug effects

Substances

  • Protein Kinase Inhibitors